Bausch Health Companies (NYSE: BHC) shares were trading higher on Tuesday, after the company announced a study arm evaluating 40 mg BID of Rifaximin SSD IR in combination with standard of care therapy met primary endpoint.
Bausch Health is a multinational specialty pharmaceutical company based in Laval, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health, and neurology.
Bausch Health shares were trading up 4.26% at $15.90 on Tuesday. The stock has a 52-week high of $31.97 and a 52-week low of $11.15.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
"Trading" - Google News
April 01, 2020 at 12:27AM
https://ift.tt/2w70qPk
Why Bausch Health's Stock Is Trading Higher Today - Benzinga
"Trading" - Google News
https://ift.tt/2tBJjTS
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Why Bausch Health's Stock Is Trading Higher Today - Benzinga"
Post a Comment